Pay in 4 interest-free payments of $5.63 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Planning your supply For a standard 20-week escalation from 2.5 mg to 15 mg: Weeks 1 to 8: one 30 mg vial (10 mg + 20 mg = 30 mg used) Weeks 9 to 12: one 30 mg vial (30 mg at 7.5 mg/week) Weeks 13 to 16: one 30 mg vial (30 mg at 10 mg/week, used in 3 weeks) Weeks 17 to 20: two 30 mg vials (60 mg at 12.5-15 mg/week) Total: approximately 4 to 5 vials for a 20-week protocol
Any AOD 9604 that is available carries many of the risks associated with unapproved peptide therapy, including potential quality concerns (e.g., mislabeling, purity, etc.)
Subcutaneous administration (which bypasses first-pass metabolism and delivers more peptide to target tissues) was not extensively tested in human trials, and this route is what most current research protocols use
Dosing Example: A 1mg dose would require a draw of 0.4 mL (or 40 units)
Preclinical rodent studies support effects on angiogenesis, endothelial function, and nitric-oxide-related signaling, though these effects are reproducible in animals but not yet validated in humans
